VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EBS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EBSEmergent BioSolutions Inc.
$8.46$437M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEBSQuarterly Financials

Emergent BioSolutions Inc. (EBS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Emergent BioSolutions Inc. (EBS) quarterly income statement — complete revenue, gross profit & net income history

EBS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue156.1M148.7M231.1M140.9M222.2M194.7M293.8M254.7M300.4M276.6M270.5M337.9M164.3M330.2M239.9M239.9M307.5M723.2M329M397.5M
Revenue Growth %-29.75%-23.63%-21.34%-44.68%-26.03%-29.61%8.61%-24.62%82.84%-16.23%12.76%40.85%-46.57%-54.34%-27.08%-39.65%-10.35%24.05%-14.59%0.71%
Cost of Goods Sold88.5M102.1M102M83.4M105.7M58.2M129.6M320.2M159.6M107.4M178.1M214.5M188.6M215.9M188.8M220.9M201.8M295.6M266.2M276.7M
COGS % of Revenue56.69%68.66%44.14%59.19%47.57%29.89%44.11%125.72%53.13%38.83%65.84%63.48%114.79%65.38%78.7%92.08%65.63%40.87%80.91%69.61%
Gross Profit67.6M46.6M129.1M57.5M116.5M136.5M164.2M-65.5M140.8M169.2M92.4M123.4M-24.3M114.3M51.1M19M105.7M427.6M62.8M120.8M
Gross Margin %43.31%31.34%55.86%40.81%52.43%70.11%55.89%-25.72%46.87%61.17%34.16%36.52%-14.79%34.62%21.3%7.92%34.37%59.13%19.09%30.39%
Gross Profit Growth %-41.97%-65.86%-21.38%187.79%-17.26%-19.33%77.71%-153.08%679.42%48.03%80.82%549.47%-122.99%-73.27%-18.63%-84.27%-45.03%20.25%-65.27%-44.33%
Operating Expenses57.1M63.2M52.3M57M67.9M146M99.7M138M101M213M334.5M416.3M123.3M169.6M96.4M94.8M99.3M150.2M97.5M106.3M
OpEx % of Revenue36.58%42.5%22.63%40.45%30.56%74.99%33.93%54.18%33.62%77.01%123.66%123.2%75.05%51.36%40.18%39.52%32.29%20.77%29.64%26.74%
Selling, General & Admin46.6M51.1M38.8M44M52.7M60.7M75.9M77.3M84.8M89.4M79.7M91.3M96.3M93.4M81.8M79.5M84.8M94.2M82.1M91.2M
SG&A % of Revenue29.85%34.36%16.79%31.23%23.72%31.18%25.83%30.35%28.23%32.32%29.46%27.02%58.61%28.29%34.1%33.14%27.58%13.03%24.95%22.94%
Research & Development10.5M12.1M13.5M13M15.2M9.1M13.8M32.7M15.1M29.4M15.3M26M40.7M47M42.2M52.7M46.4M83M49.6M48.9M
R&D % of Revenue6.73%8.14%5.84%9.23%6.84%4.67%4.7%12.84%5.03%10.63%5.66%7.69%24.77%14.23%17.59%21.97%15.09%11.48%15.08%12.3%
Other Operating Expenses000001000K1000K1000K1000K1000K1000K1000K-1000K1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income10.5M-16.6M76.8M500K48.6M-9.5M64.5M-203.5M39.8M-43.8M-242.1M-292.9M-147.6M-55.3M-45.3M-75.8M6.4M277.4M-34.7M14.5M
Operating Margin %6.73%-11.16%33.23%0.35%21.87%-4.88%21.95%-79.9%13.25%-15.84%-89.5%-86.68%-89.84%-16.75%-18.88%-31.6%2.08%38.36%-10.55%3.65%
Operating Income Growth %-78.4%-74.74%19.07%100.25%22.11%78.31%126.64%30.52%126.96%20.8%-434.44%-286.41%-2406.25%-119.94%-30.55%-622.76%-93.29%7.48%-156.61%-88.49%
EBITDA34.6M6.9M100.6M24.5M74.6M15.8M90.2M-175.9M66.8M-15.1M-215.2M-260.9M-114.1M-33.7M-1.8M-45.4M35.9M305.2M-3.4M46.2M
EBITDA Margin %22.17%4.64%43.53%17.39%33.57%8.12%30.7%-69.06%22.24%-5.46%-79.56%-77.21%-69.45%-10.21%-0.75%-18.92%11.67%42.2%-1.03%11.62%
EBITDA Growth %-53.62%-56.33%11.53%113.93%11.68%204.64%141.91%32.58%158.55%55.19%-11855.56%-474.67%-417.83%-111.04%47.06%-198.27%-70.77%6.83%-103.82%-69.92%
D&A (Non-Cash Add-back)24.1M23.5M23.8M24M26M25.3M25.7M27.6M27M28.7M26.9M32M33.5M21.6M43.5M30.4M29.5M27.8M31.3M31.7M
EBIT24.4M-36M72.8M-2.1M107.4M-4.3M72M-159.1M36.4M-42.2M-3.6M16M-137.6M3M-44.7M-74.5M6.9M319.4M-33.8M15.8M
Net Interest Income-11M-14.7M-15.2M-14.7M-14.7M-14.8M-8.3M-23.6M-24.3M-21.7M-19.7M-28.6M-17.9M-12.8M-8.5M-7.8M-8.2M-9M-8.4M-8.6M
Interest Income000000000500K0000000000
Interest Expense11M14.7M15.2M14.7M14.7M14.8M8.3M23.6M24.3M22.2M19.7M28.6M17.9M12.8M8.5M7.8M8.2M9M8.4M8.6M
Other Income/Expense2.9M-34.1M-19.2M-17.3M44.1M-18.1M77.9M-66.3M-27.7M-10.7M-23.8M42.7M-13M-6.1M-21.9M-10.8M-10.2M-9.9M-10.8M-7.3M
Pretax Income13.4M-50.7M57.6M-16.8M92.7M-27.6M142.4M-269.8M12.1M-54.5M-265.9M-250.2M-160.6M-61.4M-67.2M-86.6M-3.8M267.5M-45.5M7.2M
Pretax Margin %8.58%-34.1%24.92%-11.92%41.72%-14.18%48.47%-105.93%4.03%-19.7%-98.3%-74.05%-97.75%-18.59%-28.01%-36.1%-1.24%36.99%-13.83%1.81%
Income Tax6.6M3.9M6.4M-4.8M24.7M3.7M27.6M13.3M3.1M-5M-2.5M11.2M25.6M5.6M19.9M-32.8M-100K78.2M-12.8M2.6M
Effective Tax Rate %49.25%-7.69%11.11%28.57%26.65%-13.41%19.38%-4.93%25.62%9.17%0.94%-4.48%-15.94%-9.12%-29.61%37.88%2.63%29.23%28.13%36.11%
Net Income6.8M-54.6M51.2M-12M68M-31.3M114.8M-283.1M9M-49.5M-263.4M-261.4M-186.2M-67M-87.1M-53.8M-3.7M189.3M-32.7M4.6M
Net Margin %4.36%-36.72%22.15%-8.52%30.6%-16.08%39.07%-111.15%3%-17.9%-97.38%-77.36%-113.33%-20.29%-36.31%-22.43%-1.2%26.18%-9.94%1.16%
Net Income Growth %-90%-74.44%-55.4%95.76%655.56%36.77%143.58%-8.3%104.83%26.12%-202.41%-385.87%-4932.43%-135.39%-166.36%-1269.57%-105.31%2.1%-182.78%-95.04%
Net Income (Continuing)6.8M-54.6M51.2M-12M68M-31.3M114.8M-283.1M9M-49.5M-263.4M-261.4M-186.2M-67M-87.1M-53.8M-3.7M189.3M-32.7M4.6M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.07-1.040.91-0.221.19-0.592.06-5.380.17-0.95-5.13-5.15-3.65-1.76-1.52-1.13-0.073.50-0.610.09
EPS Growth %-93.76%-76.27%-55.83%95.91%600%37.89%140.16%-4.47%104.66%46.02%-237.5%-355.75%-4900%-150.29%-149.18%-1355.56%-105.7%1.74%-183.56%-94.8%
EPS (Basic)0.13-1.040.96-0.221.25-0.592.16-5.380.17-0.95-5.13-5.15-3.65-1.76-1.52-1.13-0.073.54-0.610.09
Diluted Shares Outstanding56.5M52.4M56.5M54.2M57.3M54.2M55.6M52.6M52.2M51.9M51.8M50.7M50.2M49.9M49.9M50M50.7M53.5M53.7M54M
Basic Shares Outstanding51.9M52.4M53.2M54.2M54.4M54.2M53.1M52.6M52.2M51.9M51.8M50.7M50.2M49.9M49.8M49.91M50.7M53.2M53.61M53.6M
Dividend Payout Ratio--------------------